½üÈÕ£¬µÏÍþÖƵÏÍþ¹ú¼ÊÒȸßѪÌÇËØÑùëÄ-1ÊÜÌ弤¶¯¼Á£¨GLP-1RA£©ÖÜÖƼÁ¾ÛÒÒ¶þ´¼ÂåÈûÄÇëÄ£¨ÉÌÆ·Ãû£ºæÚÀ´ÃÀ?£©¶ÔÌÇÄò²¡ÉË¿ÚÓúºÏµÄÓ°Ïì¼°ÆäDZÔÚ»úÖÆÑо¿½á¹û·¢±íÔÚInternational Journal of Molecular Sciences£¨¼ò³ÆINT J MOL SCI£¬¡¶¹ú¼Ê·Ö×Ó¿ÆѧÔÓÖ¾¡·£©£¬Ê״νÒʾÁËæÚÀ´ÃÀ?ͨ¹ýË«ÖØ»úÖƼÓËÙÌÇÄò²¡ÉË¿ÚÓúºÏ¡ª¡ªÏµÍ³ÐÔ¿¹Ñ×µ÷½ÚÓëѪ¹ÜÄÚƤ×æϸ°û£¨EPCs£©¹¦ÄÜÐÞ¸´£¬´Ó¶øΪÌÇÄò²¡ÂýÐÔÉË¿ÚÖÎÁÆÌṩÁËвßÂÔ¡£[1]ÌÇÄò²¡ÊÇÈ«Çò·¶Î§ÄÚµ¼ÖÂËÀÍöºÍ²Ð¼²µÄÖ÷ÒªÔÒòÖ®Ò»£¬ÆäѪ¹Ü²¢·¢Ö¢£¨ÈçÂýÐÔÉË¿ÚÓúºÏÑÓ³Ù£©ÊÇÁÙ´²ÖÎÁƵÄÖØÒªÌôÕ½¡£ÌÇÄò²¡ÉË¿ÚÓúºÏÕÏ°µÄ»úÖƸ´ÔÓ£¬Éæ¼°ÂýÐÔÑ×Ö¢¡¢Ñª¹ÜÐÂÉú²»×㡢Ѫ¹ÜÄÚƤ×æϸ°û£¨EPCs£¬¼´Ñª¹ÜÄÚƤϸ°ûµÄÇ°Ìåϸ°û£©¹¦ÄÜÊÜËð£¬ÒÔ¼°ÏßÁ£ÌåÑõ»¯Ó¦¼¤µÈ¡£Ëæ×ÅÌÇÄò²¡»¼²¡ÂʵÄÉÏÉý£¬Ñ°ÕÒÓÐЧµÄÉË¿Ú·ÀÖβßÂÔÏÔµÃÓÈΪÆÈÇС£½üÄêÀ´£¬GLP-1RAÒò¼æ¾ß½µÌǺÍÐÄѪ¹Ü±£»¤×÷Óñ¸ÊܹØ×¢¡£±±¾©ÐºÍÒ½Ôº¿ÎÌâÑо¿Ð¡×éͨ¹ýÌåÄÚÍâʵÑ飬ϵͳÆÀ¹ÀÁËæÚÀ´ÃÀ?¶ÔÌÇÄò²¡ÉË¿ÚÓúºÏµÄÓ°Ïì¼°ÆäDZÔÚ»úÖÆ£¬Ñо¿½á¹û·¢±íÔÚINT J MOL SCI¡£[1]¸ÃÑо¿Ê¹ÓÃСÊó½¨Á¢ÉË¿ÚÄ£ÐÍ£¬±È½Ï½ÓÊÜæÚÀ´ÃÀ?ÖÎÁƵÄÌÇÄò²¡Ð¡Êó£¨ÌÇÄò²¡ÖÎÁÆ×飩Óëδ½ÓÊÜÖÎÁƵÄÌÇÄò²¡Ð¡Êó£¨ÌÇÄò²¡²»ÖÎÁÆ×飩ÒÔ¼°Õý³£Ð¡Ê󣨶ÔÕÕ×飩µÄÉË¿ÚÓúºÏÇé¿ö¡£´ËÍ⣬»¹Í¨¹ýÌåÍâʵÑéÆÀ¹ÀæÚÀ´ÃÀ?¶ÔEPCs¹¦ÄܵÄÓ°Ïì¡£Ñо¿·¢ÏÖ£¬æÚÀ´ÃÀ?¾ßÓÐÒÔÏÂ×÷Óãº[1]- ¸ÄÉÆ´úлÎÉÂÒ£ºÏà±ÈÌÇÄò²¡²»ÖÎÁÆ×飬½ÓÊÜæÚÀ´ÃÀ?ÖÎÁƵÄÌÇÄò²¡Ð¡ÊóÌåÖØÃ÷ÏÔϽµ£»æÚÀ´ÃÀ?»¹¿Éͨ¹ýÌá¸ßÒȵºËØÃô¸ÐÐԺ͸ÄÉÆÆÏÌÑÌÇÇå³ýÄÜÁ¦»º½âÌÇÄò²¡´úлÎÉÂÒ¡£
- ¼ÓËÙÉË¿ÚÓúºÏ£ºÏà±ÈÕý³£Ð¡Êó£¬ÌÇÄò²¡Ð¡ÊóµÄÉË¿ÚÓúºÏËÙ¶ÈÏÔÖø½µµÍ¡£È»¶ø£¬½ÓÊÜæÚÀ´ÃÀ?ÖÎÁƵÄÌÇÄò²¡Ð¡ÊóÏà±Èδ½ÓÊÜÖÎÁƵÄÌÇÄò²¡Ð¡ÊóµÄÓúºÏËÙ¶ÈÃ÷ÏÔÌáÉý¡£
- µ÷½ÚϵͳÐÔÑ×Ö¢£ºÑªÇåµ°°×ÖÊ×éѧÏÔʾ£¬æÚÀ´ÃÀ?ÖÎÁƺó´ÙÑ×Òò×Ó£¨ÈçCCL2¡¢CCL20£©ÏÔÖøϵ÷£¬¿¹Ñ×Òò×ÓIL-5Éϵ÷¡£ÌáʾæÚÀ´ÃÀ?¿ÉÄÜͨ¹ýÒÖÖÆÂýÐÔÑ×Ö¢£¬¸ÄÉÆѪ¹ÜÐÞ¸´Î¢»·¾³£¬´Ó¶ø´Ù½øÉË¿ÚÓúºÏ¡£
- »Ö¸´EPCs¹¦ÄÜ£ºÌåÍâʵÑé±íÃ÷£¬¸ßÌÇ/¸ßÖ¬»·¾³ÏÔÖøÒÖÖÆEPCsµÄ¹ÜÐγɺÍǨÒÆÄÜÁ¦£¬¶øæÚÀ´ÃÀ?¿É²¿·Ö»Ö¸´ÕâЩ¹¦ÄÜ¡£æÚÀ´ÃÀ?¶ÔÓÚEPCs¹¦Äܵı£»¤»úÖÆ£¬Ò»·½ÃæÊÇÄܹ»½µµÍÏßÁ£Ìå»îÐÔÑõ£¨ROS£©Éú³É²¢¸ÄÉÆÏßÁ£ÌåºôÎü¹¦ÄÜ£»ÁíÒ»·½ÃæÊÇͨ¹ýÔöÇ¿ÏßÁ£Ìå×ÔÊɶøÇå³ýÊÜËðÏßÁ£Ì壬´Ó¶øά³Öϸ°ûÎÈ̬¡£
¼ÈÍùÓÐÌåÍâÊÔÑéÏÔʾ£¬ÂåÈûÄÇëÄ¿Éͨ¹ýSIRT3/Foxo3ÐźÅͨ·¸ÄÉÆEPCsËðÉ˺ÍÏßÁ£Ì幦ÄÜÕÏ°[2]¡£·¢±íÓÚMedComm£¨IF£º10.7£©µÄÊ׸öÖйúÈËȺGLP-1RAÐÄѪ¹Ü½á¾Ö´óÐÍÕæʵÊÀ½çÑо¿£¨FLYING£©£¬´ÓÁÙ´²ÉÏÖ¤Ã÷ÁËÂåÈûÄÇëĿɽµµÍ2ÐÍÌÇÄò²¡»¼ÕßÐÄѪ¹Üʼþ·¢Éú·çÏÕ[3]¡£±¾Ñо¿ÎªÂåÈûÄÇëÄÓÃÓÚÌÇÄò²¡Ñª¹Ü²¢·¢Ö¢µÄÖÎÁÆÌṩÁËÀíÂÛÖ§³Ö£¬ÎªÌÇÄò²¡ÂýÐÔÉË¿ÚÖÎÁÆÌṩÁËвßÂÔ£¬Ò²ÍØÕ¹ÁËGLP-1RAµÄÁÙ´²Ó¦ÓÃÇ°¾°£¬ÀýÈçÓÃÓÚÆäËûÏßÁ£Ì幦ÄÜÕÏ°Ïà¹Ø¼²²¡µÄÖÎÁÆ¡£Î´À´Ñо¿½«½øÒ»²½Ì½Ë÷ÆäÔÚÈËÌåÖеÄÁÆЧ¼°·Ö×Óµ÷¿ØÍøÂç¡£[1] Ding Z, Yang C, Zhai X, Xia Y, Liu J, Yu M. Polyethylene Glycol Loxenatide Accelerates Diabetic Wound Healing by Downregulating Systemic Inflammation and Improving Endothelial Progenitor Cell Functions. Int J Mol Sci. 2025;26(5):2367.[2] Yuan J, Wang Y, Wang D, Yan H, Wang N. Loxenatide attenuates ROS-mediated vascular endothelial progenitor cell damage and mitochondrial dysfunction via SIRT3/Foxo3 signaling pathway. J Biochem Mol Toxicol. 2023;37(11):e23452.
[3] Li J, Tian Y, Li L, et al. Once-weekly glucagon-like peptide receptor agonist polyethylene glycol loxenatide protects against major adverse cardiovascular events in patients with type 2 diabetes: a multicenter ambispective cohort study (FLYING trial). MedComm (2020). 2025;6(2):e70094.ÉùÃ÷£º
1¡¢±¾¹«¸æ½ö¹©Ò½ÁÆÎÀÉúרҵÈËÊ¿²ÎÔÄ£¬·Ç¹ã¸æÓÃ;¡£
2¡¢µÏÍþÖƵÏÍþ¹ú¼Ê²»ÍƼöÈκÎδ»ñÅúµÏÍþ¹ú¼ÊƷʹÓúÍ/»òδ»ñÅúÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼Ê£¬Ò಻¶ÔÈκεÏÍþ¹ú¼ÊÆ·ºÍ/»òÊÊÓ¦Ö¢×÷ÍƼö¡£
3¡¢±¾¹«¸æÖÐÉæ¼°µÄÐÅÏ¢½ö¹©²Î¿¼£¬Çë×ñ´ÓÒ½Éú»òÆäËûÒ½ÁÆÎÀÉúרҵÈËÊ¿µÄÒâ¼û»òÖ¸µ¼¡£Ò½ÁÆÎÀÉúרҵÈËÊ¿×÷³öµÄÈκÎÓëÖÎÁÆÓйصľö¶¨Ó¦¸ù¾Ý»¼ÕߵľßÌåÇé¿ö²¢×ñÕÕµÏÍþ¹ú¼ÊƷ˵Ã÷Êé¡£
4¡¢ÈçÐèÁ˽⹫˾ÈκβúÆ·¡¢Ò½ÁÆ»ò¼²²¡µÄÏà¹ØÐÅÏ¢£¬ÇëÎñ±Ø×ÉѯҽÁÆÎÀÉúרҵÈËÊ¿¡£
µÏÍþÖƵÏÍþ¹ú¼ÊÊÇÖйúÁìÏȵĴ´ÐÂÇý¶¯ÐÍÖƵÏÍþ¹ú¼ÊÆóÒµ£¬ÒÔ¡¸³ÖÐø´´Ð£¬Ìá¸ßÈËÀàÉúÃüÖÊÁ¿¡¹ÎªÊ¹Ãü£¬Öصã¹Ø×¢¿¹Ö×Áö¡¢¿¹¸ÐȾ¡¢ÖÐÊàÉñ¾ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò¡£½ØÖÁÄ¿Ç°£¬¹«Ë¾ÒÑÉÏÊÐ7¿î´´ÐµÏÍþ¹ú¼Ê£¬ÐγÉÁ˷ḻµÄ²úÆ·¹ÜÏß¡£µÏÍþÖƵÏÍþ¹ú¼ÊÁ¬Ðø¶àÄêλ¾ÓÈ«ÇòÖƵÏÍþ¹ú¼ÊÆóÒµ°ÙÇ¿¡¢ÖйúÒ½µÏÍþ¹ú¼ÊÑз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿£¬Êǹú¼ÒÖصã¸ßм¼ÊõÆóÒµ¡¢¹ú¼Ò¼¼Êõ´´ÐÂʾ·¶ÆóÒµ¡£µÏÍþÖƵÏÍþ¹ú¼ÊÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊУ¨¹ÉƱ´úÂ룺03692.HK£©¡£±¾ÎÄÖ¼ÔÚÌṩÓйء°µÏÍþÖƵÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾¡±»òÆä×Ó¹«Ë¾µÈ¹ØÁª·½£¨Í³³Æ¡°¹«Ë¾¡±£©µÄÏà¹ØÐÅÏ¢£¬²»¹¹³É¹«Ë¾ÐÅÏ¢Åû¶»òͶ×ÊÍƼö¡£
±¾ÎÄËù·¢²¼µÄÐÅÏ¢ÖпÉÄÜ»á°üº¬Ä³Ð©Ç°Õ°ÐÔ±íÊö£¬ÀýÈçÉæ¼°ÒµÎñºÍ²úÆ·Ç°¾°£¬»ò¹«Ë¾¼Æ»®¡¢ÈÏÖª¡¢Ô¤ÆÚ¼°²ßÂÔ¡£ÕâЩ±íÊöÊǽ¨Á¢ÔÚÍƲâÐÔ¼ÙÉèµÄÊý¾Ý»ù´¡ÉϵÄÔ¤²â£¬²¢·ÇÊǶÔδÀ´·¢Õ¹µÄ±£Ö¤£¬ÒòÆäÐÔÖÊʹȻ¾ùÊÜÏà¹Ø·çÏպͲ»È·¶¨ÒòËØÓ°Ï죬ÆäÖв¿·Ö»¹²»Êܹ«Ë¾¿ØÖÆÇÒÄÑÒÔÔ¤ÁÏ£¬Í¶×ÊÕß½øÐÐͶ×ʾö²ßʱӦ½÷É÷ʹÓá£ÔÚʹÓá°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÏàÐÅ¡±¡°Ô¤²â¡±¡°ÆÚÍû¡±¼°ÆäËûÀàËÆ´ÊÓï½øÐбíÊöʱ£¬·²Ó빫˾ÓйصÄÐÅÏ¢±íÊö£¬¾ùÊôÓÚÇ°Õ°ÐÔ±íÊö¡£¹«Ë¾²¢ÎÞÒåÎñ¸üлòÐÞ¸ÄÕâЩǰհÐÔ±íÊö£¬¹«Ë¾¡¢¹«Ë¾¶Ê¡¢¹ÍÔ±¡¢´úÀí¸Å²»³Ðµ£ÒòÈκÎÇ°Õ°ÐÔ±íÊö²»ÄÜʵÏÖ»ò±ä³É²»ÕýÈ·¶øÒýÖµÄÈκÎÔðÈΡ£
±¾ÐÂΟåÖеÄËùÓÐÐÅÏ¢½ö¼°ÓÚÐÂΟ巢²¼Ö®ÈÕ£¬ÎÞÂÛÊÇ·ñ³öÏÖÐÂ×ÊÁÏ¡¢Î´À´Ê¼þ»òÆäËûÇé¿ö£¬³ý·Ç·¨ÂÉÒªÇ󣬹«Ë¾²¢ÎÞÔðÈλòÒåÎñ¸üлòÐ޸ĸõÈÐÅÏ¢¡£Í¶×ÊÕßÒ˲ÎÕÕµÏÍþÖƵÏÍþ¹ú¼Ê£¨03692.HK£©¹«¸æ¼°²Æ±¨£¬ÒÔ»ñÈ¡½öÓëÉÏÊй«Ë¾ÓйصÄÐÅÏ¢¡£
¼ò
¤™
